SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-22-017852
Filing Date
2022-05-04
Accepted
2022-05-04 16:12:01
Documents
14
Period of Report
2022-05-04
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K adpt-8k_20220504.htm   iXBRL 8-K 39664
2 EX-99.1 adpt-ex991_6.htm EX-99.1 436506
3 GRAPHIC gb1tgphfl15k000001.jpg GRAPHIC 7887
  Complete submission text file 0001564590-22-017852.txt   630704

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA adpt-20220504.xsd EX-101.SCH 5617
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE adpt-20220504_lab.xml EX-101.LAB 18574
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE adpt-20220504_pre.xml EX-101.PRE 11056
8 EXTRACTED XBRL INSTANCE DOCUMENT adpt-8k_20220504_htm.xml XML 3434
Mailing Address 1165 EASTLAKE AVE E SEATTLE WA 98109
Business Address 1165 EASTLAKE AVE E SEATTLE WA 98109 206-659-0067
Adaptive Biotechnologies Corp (Filer) CIK: 0001478320 (see all company filings)

IRS No.: 270907024 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38957 | Film No.: 22891624
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences